Quest Diagnostics Quarterly Income Statement
NYSE: DGXHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Quest Diagnostics revenue and earnings
In the quarter ended Jun 30, 2026, Quest Diagnostics generated $3.04 billion in revenue, up 10.2% from the same quarter a year earlier. Net income was $320.0 million (+13.5% year over year), for a net margin of 10.5% versus a median of 8.7% in the prior 5 quarters. Gross margin was 33.7% (down from 34.2%) and operating margin 15.1%.
Diluted earnings per share came in at $2.84, up from $2.47.
Summary generated from market data by MetaCap's automated system. Methodology
Quest Diagnostics income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.04B | 2.90B | 2.81B | 2.82B | 2.76B | 2.65B | 2.62B | 2.49B | 2.40B | 2.37B | 2.29B | 2.29B |
| Revenue growth (YoY) | +10.21% | +9.16% | +7.06% | +13.18% | +15.19% | +12.09% | +14.55% | +8.41% | +2.52% | +1.50% | -1.93% | -7.68% |
| Cost of Revenue | 2.02B | 1.95B | 1.90B | 1.87B | 1.82B | 1.79B | 1.76B | 1.68B | 1.59B | 1.59B | 1.55B | 1.54B |
| Gross Profit | 1.03B | 942.00M | 910.00M | 949.00M | 943.00M | 863.00M | 858.00M | 811.00M | 804.00M | 771.00M | 736.00M | 754.00M |
| Operating Expenses | 568.00M | 543.00M | 524.00M | 563.00M | 505.00M | 517.00M | 497.00M | 481.00M | 449.00M | 471.00M | 469.00M | 412.00M |
| Selling, General & Admin | 529.00M | 504.00M | 504.00M | 501.00M | 486.00M | 476.00M | 466.00M | 448.00M | 416.00M | 440.00M | 407.00M | 380.00M |
| Operating Income | 459.00M | 399.00M | 386.00M | 386.00M | 438.00M | 346.00M | 361.00M | 330.00M | 355.00M | 300.00M | 267.00M | 342.00M |
| Interest Expense | 68.00M | 65.00M | 67.00M | 69.00M | 69.00M | 72.00M | 72.00M | 58.00M | 47.00M | 49.00M | 46.00M | 41.00M |
| Other Income (Expense) | -47.00M | -65.00M | -56.00M | -58.00M | -54.00M | -70.00M | -62.00M | -34.00M | -41.00M | -34.00M | -30.00M | -43.00M |
| Pretax Income | 412.00M | 334.00M | 330.00M | 328.00M | 384.00M | 276.00M | 299.00M | 296.00M | 314.00M | 266.00M | 237.00M | 299.00M |
| Income Tax | 88.00M | 74.00M | 81.00M | 77.00M | 97.00M | 59.00M | 68.00M | 65.00M | 74.00M | 66.00M | 40.00M | 68.00M |
| Net Income | 320.00M | 252.00M | 245.00M | 245.00M | 282.00M | 220.00M | 222.00M | 226.00M | 229.00M | 194.00M | 192.00M | 225.00M |
| Net Income growth (YoY) | +13.48% | +14.55% | +10.36% | +8.41% | +23.14% | +13.40% | +15.63% | +0.44% | -2.55% | -3.96% | +90.10% | -12.11% |
| EPS (Basic) | 2.88 | 2.27 | 2.21 | 2.18 | 2.51 | 1.97 | 1.98 | 2.01 | 2.05 | 1.74 | 1.72 | 1.99 |
| EPS (Diluted) | 2.84 | 2.24 | 2.18 | 2.16 | 2.47 | 1.94 | 1.95 | 1.99 | 2.03 | 1.72 | 1.70 | 1.96 |
| Shares Outstanding (Basic) | 111.00M | 110.00M | — | 112.00M | 112.00M | 111.00M | — | 112.00M | 111.00M | 111.00M | — | 112.00M |
| Shares Outstanding (Diluted) | 112.00M | 112.00M | — | 113.00M | 113.00M | 113.00M | — | 113.00M | 112.00M | 112.00M | — | 114.00M |
| EBITDA | 605.00M | 546.00M | 531.00M | 528.00M | 581.00M | 486.00M | 496.00M | 455.00M | 472.00M | 416.00M | 376.00M | 453.00M |
| Gross Margin | 33.75% | 32.54% | 32.43% | 33.70% | 34.15% | 32.54% | 32.74% | 32.60% | 33.54% | 32.59% | 32.17% | 32.85% |
| Operating Margin | 15.08% | 13.78% | 13.76% | 13.71% | 15.86% | 13.05% | 13.77% | 13.26% | 14.81% | 12.68% | 11.67% | 14.90% |
| Net Margin | 10.52% | 8.70% | 8.73% | 8.70% | 10.21% | 8.30% | 8.47% | 9.08% | 9.55% | 8.20% | 8.39% | 9.80% |
This table shows 12 quarterly periods of Quest Diagnostics's income statement, from Q2 2026 back to Q3 2023, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow DGX's reporting calendar. What is a income statement?